What is one component of dyslipidemia associated with obesity?

Dyslipidemia associated with obesity is characterized by abnormal levels of lipids in the blood, which can include both increased and decreased levels of specific lipid types. One prominent component of this condition is decreased levels of high-density lipoprotein (HDL) cholesterol, often referred to as "good" cholesterol. HDL is essential for the removal of cholesterol from the bloodstream, and lower levels are associated with increased cardiovascular risk.

In obesity, the metabolic changes that occur can lead to a reduction in HDL cholesterol levels. This reduction is significant because higher levels of HDL are generally protective against heart disease. When a person is obese, factors such as insulin resistance and inflammation can contribute to this dyslipidemic profile, affecting lipid metabolism and leading to lower HDL levels.

While high LDL (low-density lipoprotein) levels and high insulin levels can also be seen in obesity, they do not specifically define the dyslipidemic profile as clearly as the decrease in HDL does. Additionally, low triglyceride levels are atypical in the context of obesity-related dyslipidemia, which usually presents with elevated triglyceride levels. Thus, decreased HDL stands out as a key component of dyslipidemia linked to obesity.